Program Offering and Eligibility

If you have commercial insurance and meet the additional eligibility criteria below, you can get help with your Rituxan drug costs, infusion costs or both.

Note: This program helps with the drug and infusion costs of Rituxan only. It does not help with the cost of other medicines you take at the same time as Rituxan or with facility fees.

 

Help with Rituxan drug costs

You may pay $5 for each Rituxan treatment.*
You receive up to $15,000 every 12 months to help with your Rituxan drug costs.

Help with Rituxan infusion costs

You may pay $5 for each Rituxan infusion.*
You receive up to $2,000 every 12 months to help with your Rituxan infusion costs.

 
*The final amount owed by patients may be as little as $5, but may vary depending on the patient's health insurance plan. Eligible commercially insured patients who are prescribed Rituxan for an FDA-approved use can receive up to $15,000 in assistance per 12-month period for drug costs and/or up to $2,000 in infusion assistance per 12-month period for infusion costs. See terms and conditions for each program. Program limits apply.

Eligibility for help with drug costs

You may be eligible if you:
  • Are taking Rituxan for one of the following FDA-approved uses:
    • Moderately to severely active rheumatoid arthritis (RA) in combination with methotrexate and you have had an inadequate response to one or more Tumor Necrosis Factor (TNF) antagonist therapies (adult patients only)
    • Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA) in combination with glucocorticoids (patients 2 years of age and older)
    • Moderate to severe Pemphigus Vulgaris (PV) (adult patients only)
  • Are 18 years of age or older or have a legal guardian over the age of 18 to manage the program (for GPA and MPA patients under 18 only)
  • Have commercial (private or non-governmental) insurance
  • Do not use a federal or state health insurance program. This includes, but is not limited to, Medicare, Medicaid, Medigap, VA, DoD or TRICARE
  • Do not currently receive help for Rituxan from the Genentech Patient Foundation or any independent co-pay assistance foundations
  • Live and are treated in the United States or U.S. Territories
  • Do not live in any state where the program is prohibited by law

Commercial insurance is an insurance plan you get from a private health insurance company. This can be insurance from your job, from a plan you bought yourself or from a Health Insurance Marketplace (for example, from HealthCare.gov). Medicare and Medicaid are not considered commercial insurance.

 

Eligibility for help with infusion costs

You may be eligible if you:
  • Are taking Rituxan for one of the following FDA-approved uses:
    • Moderately to severely active rheumatoid arthritis (RA) in combination with methotrexate and you have had an inadequate response to one or more Tumor Necrosis Factor (TNF) antagonist therapies (adult patients only)
    • Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA) in combination with glucocorticoids (patients 2 years of age and older)
    • Moderate to severe Pemphigus Vulgaris (PV) (adult patients only)
  • Are 18 years of age or older or have a legal guardian over the age of 18 to manage the program (for GPA and MPA patients under 18 only)
  • Have commercial (private or non-governmental) insurance
  • Do not use a federal or state health insurance program. This includes, but is not limited to, Medicare, Medicaid, Medigap, VA, DoD or TRICARE
  • Do not currently receive help for Rituxan from any independent co-pay assistance foundations
  • Live and are treated in the United States or U.S. Territories
  • Do not live in any state where the program is is prohibited by law

Commercial insurance is an insurance plan you get from a private health insurance company. This can be insurance from your job, from a plan you bought yourself or from a Health Insurance Marketplace (for example, from HealthCare.gov). Medicare and Medicaid are not considered commercial insurance.

You may use the Rituxan Immunology Co-pay Program for your infusion costs if you are receiving Rituxan from the Genentech Patient Foundation.

 

If you aren't eligible for the Rituxan Immunology Co-pay Program, you may still be able to get help

Genentech is committed to helping you get your Rituxan. If you can't use the Rituxan Immunology Co-pay Program, there may be other options. Call the Genentech Patient Resource Center at (877) 436-3683 with questions or to get started.

If you would like more information about Rituxan, please visit RituxanForRA.com; or call (877) 436-3683.

Indication and Important Safety Information

Rituxan is a prescription medicine used to treat:

Adults with Rheumatoid arthritis (RA): with another prescription medicine called methotrexate, to reduce the signs and symptoms of moderate to severe active RA, after treatment with at least one other medicine called a tumor necrosis factor (TNF) antagonist has been used and did not work well enough.

People with Granulomatosis with Polyangiitis (GPA) (Wegener's Granulomatosis) and Microscopic Polyangiitis (MPA) ages 2 years and above: with glucocorticoids.

Adults with Pemphigus Vulgaris (PV): to treat moderate to severe PV.

Rituxan is not indicated in children less than 2 years of age with GPA or MPA or in children with conditions other than GPA or MPA.

What is the most important information I should know about Rituxan?

Rituxan can cause serious side effects that can lead to death, including:

  • Infusion-Related Reactions: Infusion-related reactions are very common side effects of Rituxan treatment. Serious infusion-related reactions can happen during your infusion or within 24 hours after your infusion of Rituxan. Your healthcare provider should give you medicines before your infusion of Rituxan to decrease your chance of having a severe infusion-related reaction
  • Severe Skin and Mouth Reactions: Tell your healthcare provider or get medical help right away if you get any of these symptoms at any time during your treatment with Rituxan: painful sores or ulcers on your skin, lips, or in your mouth; blisters; peeling skin; rash; or pustules
  • Hepatitis B Virus (HBV) Reactivation: If you have had hepatitis B or are a carrier of hepatitis B virus, receiving Rituxan could cause the virus to become an active infection again. Hepatitis B reactivation may cause serious liver problems, including liver failure and death. You should not receive Rituxan if you have active hepatitis B liver disease. Your healthcare provider will monitor you for hepatitis B infection during and for several months after you stop receiving Rituxan
  • Progressive Multifocal Leukoencephalopathy (PML): PML is a rare, serious brain infection caused by a virus that can happen in people who receive Rituxan. People with weakened immune systems can get PML. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML

Before receiving Rituxan, patients should tell their healthcare provider if they:

  • have had a severe reaction to Rituxan or a rituximab product
  • currently have or have a history of other medical conditions, especially heart disease
  • have had a severe infection, currently have an infection, or have a weakened immune system
  • have had a recent vaccination or are scheduled to receive vaccinations
  • are pregnant or planning to become pregnant. Females who are able to become pregnant: the patient's health care provider should do a pregnancy test to see if they are pregnant before starting Rituxan and should use effective birth control (contraception) during treatment with Rituxan and for 12 months after the last dose of Rituxan
  • are breastfeeding or plan to breastfeed. Patients should not breastfeed during treatment and for 6 months after the last dose of Rituxan
  • are taking any medications, including prescription and over-the-counter medicines, vitamins, and herbal supplements

What are the possible side effects of Rituxan?

Rituxan can cause serious and life-threatening side effects, including:

  • Tumor Lysis Syndrome (TLS): TLS is caused by the fast breakdown of cancer cells. TLS can cause you to have kidney failure and the need for dialysis treatment or may cause an abnormal heart rhythm. Tell your healthcare provider right away if you have any of the following signs or symptoms of TLS: nausea, vomiting, diarrhea, or lack of energy
  • Serious Infections: Serious infections can happen during and after treatment with Rituxan and can lead to death. Rituxan can increase your risk of getting infections and can lower the ability of your immune system to fight infections. People with serious infections should not receive Rituxan
  • Heart Problems: Rituxan may cause chest pain, irregular heartbeats, and heart attack. Your healthcare provider may monitor your heart during and after treatment with Rituxan if you have symptoms of heart problems or have a history of heart problems
  • Kidney Problems: especially if you are receiving Rituxan for non–Hodgkin's lymphoma (NHL). Your healthcare provider should do blood tests to check how well your kidneys are working
  • Stomach and Serious Bowel Problems That Can Sometimes Lead to Death: Tell your healthcare provider right away if you have any stomach-area pain during treatment with Rituxan

What are common side effects during treatment with Rituxan?

The most common side effects of Rituxan include:

  • infusion-related reactions
  • infections (may include fever, chills)
  • body aches
  • tiredness
  • nausea

In adults with GPA or MPA, the most common side effects of Rituxan also include:

  • low white and red blood cells
  • swelling
  • diarrhea
  • muscle spasms

Other side effects with Rituxan include:

  • aching joints during or within hours of receiving an infusion
  • more frequent upper respiratory tract infections

These are not all of the possible side effects with Rituxan.

Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555.

Please see the Rituxan Prescribing Information and Medication Guide including Most Serious Side Effects for additional Important Side Effect Information.